As disease-specific genome sequencing advances in scope, we feel confident that deleterious PIMT variants, several of which are described here, will arise as contributors to one or more neurological diseases in the young, and to progressive CNS disorders in the aged. Here, PCMT1 is linked to central nervous system disorder.